These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35915373)

  • 1. Sex-Based Clinicopathologic and Survival Differences Among Patients with Pancreatic Neuroendocrine Tumors.
    Greenberg JA; Ivanov NA; Egan CE; Lee YJ; Zarnegar R; Fahey TJ; Finnerty BM; Min IM
    J Gastrointest Surg; 2022 Nov; 26(11):2321-2329. PubMed ID: 35915373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype-Phenotype Correlations.
    Soczomski P; Jurecka-Lubieniecka B; Krzywon A; Cortez AJ; Zgliczynski S; Rogozik N; Oczko-Wojciechowska M; Pawlaczek A; Bednarczuk T; Jarzab B
    Front Endocrinol (Lausanne); 2021; 12():681013. PubMed ID: 34122352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing.
    Wong HL; Yang KC; Shen Y; Zhao EY; Loree JM; Kennecke HF; Kalloger SE; Karasinska JM; Lim HJ; Mungall AJ; Feng X; Davies JM; Schrader K; Zhou C; Karsan A; Jones SJM; Laskin J; Marra MA; Schaeffer DF; Gorski SM; Renouf DJ
    Cold Spring Harb Mol Case Stud; 2018 Feb; 4(1):. PubMed ID: 29092957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features and long-term prognosis of purely cystic pancreatic neuroendocrine tumors: A single-center experience.
    Ren SJ; Wang X; Ke NW; Tan QQ; Yang F; Yao WQ; Tan CL; Liu XB
    Asian J Surg; 2023 Feb; 46(2):774-779. PubMed ID: 35850904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients.
    Qiu W; Christakis I; Silva A; Bassett RL; Cao L; Meng QH; Gardner Grubbs E; Zhao H; Yao JC; Lee JE; Perrier ND
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):400-7. PubMed ID: 27256431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
    Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
    Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of Pancreatic Neuroendocrine Tumors.
    Mohindroo C; McAllister F; De Jesus-Acosta A
    Hematol Oncol Clin North Am; 2022 Oct; 36(5):1033-1051. PubMed ID: 36154786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinicopathologic factors in 122 patients with resected pancreatic and ileal neuroendocrine tumors from a single institution.
    Dahdaleh FS; Calva-Cerqueira D; Carr JC; Liao J; Mezhir JJ; O'Dorisio TM; Howe JR
    Ann Surg Oncol; 2012 Mar; 19(3):966-72. PubMed ID: 21845496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors.
    Chou WC; Lin PH; Yeh YC; Shyr YM; Fang WL; Wang SE; Liu CY; Chang PM; Chen MH; Hung YP; Li CP; Chao Y; Chen MH
    Int J Biol Sci; 2016; 12(12):1523-1532. PubMed ID: 27994516
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of Tumor Prognosis of Pancreatic Neuroendocrine Tumors Using Image, Surgical and Pathologic Findings.
    Chen F; Huang Y; Chen C; Zhang Y; Zhang Y; Wan R; Xu M
    Neuro Endocrinol Lett; 2023 Oct; 44(7):453-464. PubMed ID: 37874552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis.
    Mei W; Cao F; Lu J; Qu C; Fang Z; Li J; Li F
    Front Endocrinol (Lausanne); 2023; 14():1140873. PubMed ID: 37020595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients: Results From the DutchMEN Study Group.
    Klein Haneveld MJ; van Treijen MJC; Pieterman CRC; Dekkers OM; van de Ven A; de Herder WW; Zandee WT; Drent ML; Bisschop PH; Havekes B; Vriens MR; Verrijn Stuart AA; Valk GD; van Leeuwaarde RS
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3515-3525. PubMed ID: 34333645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort.
    Bolm L; Nebbia M; Wei AC; Zureikat AH; Fernández-Del Castillo C; Zheng J; Pulvirenti A; Javed AA; Sekigami Y; Petruch N; Qadan M; Lillemoe KD; He J; Ferrone CR;
    Ann Surg; 2022 Sep; 276(3):522-531. PubMed ID: 35758433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors.
    Sun Y; Wang Y; Li R; Kang G; Zhang M; Chen X; Jin M; Liu Y; He Y; Zhu X; Kang Q; Zhou F; Yu Q
    Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101432. PubMed ID: 32386797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).
    Hashim YM; Trinkaus KM; Linehan DC; Strasberg SS; Fields RC; Cao D; Hawkins WG
    Ann Surg; 2014 Feb; 259(2):197-203. PubMed ID: 24253141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.
    Gratian L; Pura J; Dinan M; Roman S; Reed S; Sosa JA
    Ann Surg Oncol; 2014 Oct; 21(11):3515-21. PubMed ID: 24841347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is estrogen exposure a protective factor for pancreatic neuroendocrine tumours in female patients with multiple endocrine neoplasia syndrome type 1?
    Qiu W; Christakis I; Stewart AA; Vodopivec DM; Silva-Figueroa A; Chen H; Woodard TL; Halperin DM; Lee JE; Yao JC; Perrier ND
    Clin Endocrinol (Oxf); 2017 Jun; 86(6):791-797. PubMed ID: 28273369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of the preoperative main pancreatic duct dilation and neutrophil-to-lymphocyte ratio in pancreatic neuroendocrine tumors (PNETs) of the head after curative resection.
    Zhou B; Zhan C; Xiang J; Ding Y; Yan S
    BMC Endocr Disord; 2019 Nov; 19(1):123. PubMed ID: 31718651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors.
    Titan AL; Norton JA; Fisher AT; Foster DS; Harris EJ; Worhunsky DJ; Worth PJ; Dua MM; Visser BC; Poultsides GA; Longaker MT; Jensen RT
    JAMA Netw Open; 2020 Nov; 3(11):e2024318. PubMed ID: 33146734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Progression, Recurrence, and Survival in Pancreatic Neuroendocrine Tumors: A Single Center Analysis of 174 Patients.
    Krogh S; Grønbæk H; Knudsen AR; Kissmeyer-Nielsen P; Hummelshøj NE; Dam G
    Front Endocrinol (Lausanne); 2022; 13():925632. PubMed ID: 35837305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.